French-to-English Licence Translation for Pharmaceutical Drug Registration

Inside a French Pharmaceutical Licence: Structure and Key Terms

A French pharmaceutical licence, formally an autorisation de mise sur le marché (AMM), is a detailed regulatory document issued by a national health authority. It grants permission to market a specific medicinal product within the issuing country. In Francophone West Africa, variants of this marketing authorisation document follow a shared structure that has evolved from French administrative practice. Understanding the document’s anatomy is the first step toward a reliable translation.

Typical Licence Sections

A standard AMM includes the product’s proprietary and international nonproprietary names, a full qualitative and quantitative composition of active substances and excipients, the pharmaceutical form and dosage, therapeutic indications, posology, contraindications, and special warnings. The document also names the manufacturer and the holder of the authorisation, specifies labelling and packaging requirements, and states the validity period of the licence. A decision number and the issuing authority’s official stamp complete the dossier. Every one of these fields must be rendered accurately in translation, because even a minor slip in therapeutic class or dosage language can stall a regulatory review.

Key French Vocabulary Table

French Term	English Translation
Autorisation de mise sur le marché (AMM)	Marketing authorisation
Principe actif	Active ingredient
Excipient	Excipient (inactive ingredient)
Posologie	Posology / dosage instructions
Contre-indication	Contraindication
Forme pharmaceutique	Pharmaceutical form (e.g., tablet, syrup)
Titulaire de l’autorisation	Authorisation holder
Conditionnement	Packaging
Date de délivrance	Date of issue
Validité	Validity period

Why Translate a French Drug Licence to English

Drug registration and import approval in non-Francophone jurisdictions regularly require an English version of the original French AMM. Regulatory agencies in Anglophone West Africa, the Caribbean, or Asia may need to review the product’s composition, therapeutic class, and manufacturing details before issuing their own marketing authorisation or import permit. Pharmaceutical companies, contract research organisations, and distributors use the translation for internal regulatory review, due diligence during product acquisition, and compliance audits. In short, an accurate English text turns a French administrative document into an actionable record that regulators, partners, and legal teams can read without relying on a bilingual in‑house expert. The WHO framework for national regulatory authorities underpins the importance of clear, accessible product information across language barriers.

AI Translation vs. Official Certified Work for Drug Licence Documents

Lekhak’s instant AI translation is designed for speed and self‑service: upload a scanned AMM and receive a formatted English DOCX in minutes. This output is enough for internal review, pre‑submission preparation, understanding the product’s composition and indications, or building a working draft of a registration dossier. When a health authority, embassy, or court requires a certified translation, one accompanied by a statement of accuracy, the self‑serve AI document is not itself a certificate. For those formal submissions, Lekhak offers certified translation on‑demand, arranged outside the instant self‑serve flow. This dual‑path model keeps routine work fast and affordable while still giving you a route to an official, signed translation when the destination authority insists on one.

What You Get from Lekhak’s AI Translation

After you upload a French drug licence, whether a crisp PDF or a scanned image, the platform runs the file through optical character recognition, translates it, and assembles a clean English DOCX. Tables are preserved; dates, decision numbers, and product‑specific details are carried over without alteration. The output is a fully editable Word document that mirrors the original licence’s structure, not a raw text dump. No courier, no appointment, no waiting for business hours. Because the AI pipeline works in minutes, you can iterate quickly: if a term needs adjustment based on your company’s internal glossary, you can edit the DOCX directly. For pricing details, visit lekhak.app/pricing.

When Notarisation, Apostille, or Embassy Attestation Is Needed

For a final submission to a ministry of health, a drug regulatory authority, or a foreign embassy, the recipient may ask for a translation that has been notarised or carries an apostille. These are separate steps that the requester arranges through a notary public and, for Hague Convention countries, the competent authority in the country that issued the document. Lekhak’s on‑demand certified translation can serve as the base document in that chain, but notarisation and apostille are government acts performed outside the platform. If the destination country is not a Hague signatory, embassy attestation at its consulate may also be required. All of these steps are the responsibility of the document holder, not of the translation service.

Regional Variations: Burkina Faso, Mali, and UEMOA Licences

Marketing authorisations issued within the West African Economic and Monetary Union (UEMOA) area can differ in layout and terminology even though they all follow a French administrative template. In Burkina Faso, the national agency ANRP (under the Ministry of Health) issues AMMs with a decision number and often an annex listing the full technical file. In Mali, the Ministry of Health grants authorisations through its national commission for marketing authorizations, and the licence may include a wholesale price notation. UEMOA‑wide pharmaceutical guidelines aim to harmonise the approval process, but local formats still vary. The translator must adapt to whether the document is a single‑page certificate or a multi‑page dossier with attached product‑characteristics summaries.

The Regulatory Framework Behind French Drug Licences

A French‑language AMM is rooted in a system of pharmaceutical regulation that balances public health and commercial access. National commissions for marketing authorizations, such as the one in Mali, review technical files that cover quality, safety, and efficacy before recommending approval. In Burkina Faso, ANRP performs a similar evaluative role. UEMOA’s pharmaceutical harmonisation project introduces common guidelines for product composition, labelling, and inspection, yet the final decision remains a sovereign government act. This background is purely informational, not legal advice, but it helps explain why the language of a licence is so precise: every clause reflects a regulatory judgement that must be conveyed without distortion in translation.

Frequently Asked Questions

What is an AMM?

AMM stands for autorisation de mise sur le marché, the French term for a marketing authorisation. It is the official licence that permits a pharmaceutical product to be sold in a specific country.

Can I get an instant English translation of my French drug licence?

Yes. Upload your PDF or scanned licence to Lekhak and you will receive a formatted English DOCX in minutes, preserving all tables, dates, and product identifiers.

Is the AI translation accepted by health authorities?

For final formal submission, many health authorities require a certified translation backed by a signed statement of accuracy. Lekhak provides certified translation on‑demand for those cases; the instant self‑serve output is suitable for internal review, preparatory work, and understanding the document.

How is the translation formatted?

You receive a Word DOCX file that mirrors the original document’s structure. Tables, decision numbers, and fields like product name, active ingredients, and validity period remain intact and clearly laid out.

What information does a typical French pharmaceutical licence contain?

It lists the product name, active substances, excipients, pharmaceutical form, dosage, therapeutic indications, contraindications, the manufacturer, the authorisation holder, labelling requirements, and the validity period, plus an official decision number and stamp.

Do I need a certified translation for drug import approval?

It depends on the destination regulator. Many import‑approval processes start with a draft translation for internal review; the final submission may demand a certified version. Lekhak’s on‑demand certified translation covers the latter scenario when required.

What is ANRP?

ANRP is Burkina Faso’s national agency for the regulation of pharmacy and medicines. It operates under the Ministry of Health and issues marketing authorisations for pharmaceutical products sold in Burkina Faso.

How does UEMOA affect drug licences?

UEMOA, the West African Economic and Monetary Union, promotes harmonised pharmaceutical guidelines among its eight member states, which can influence the format and terminology of locally issued AMMs while allowing national variations.

Can I translate a scanned image of a licence?

Absolutely. Lekhak’s platform includes optical character recognition that extracts text from JPEG, PNG, or scanned PDF uploads before translating the content into English.

What does it cost to translate a drug licence?

Lekhak’s self‑serve AI translation uses a credit‑based model. For the latest per‑page rates, see the pricing page at lekhak.app/pricing. A free trial with 250 sign‑up credits is available without a credit card.